Drug News-eMediNews:Health & Medicine Updates

Thursday, May 23, 2013 | Updated 22:21 IST

http://www.heartcarefoundationofindia.org/

https://www.facebook.com/pages/World-Fellowship-of-Religions/187532511301936

eMedinewS

US FSA issued an advisory that varenicline

US FSA issued an advisory that varenicline may increase the risk of adverse cardiovascular events in patients with known cardiovascular disease. However, theMore...

FDA Okays hand-held scanner to spot clots in brain

The FDA has cleared the first hand-held device for the detection of intracranial hematoma. The Infrascanner Model 1000 uses near-infrared light to detect hematomas through differences in
More...

The US FDA is now investigating post marketing reports of serious bleeding events in patients tak

The US FDA is now investigating post marketing reports of serious bleeding events in patients taking dabigatran. FDA is working to
More...

1. The US FDA is now investigating post marketing reports of serious bleeding events in patients tak

The US FDA is now investigating post marketing reports of serious bleeding events in patients taking dabigatran. FDA is working to
More...

Other Drug News Article

1. The US FDA is now investigating post marketing reports of serious bleeding events in patients tak
The US FDA is now investigating post marketing reports of serious bleeding events in patients taking dabigatran. FDA is working to More »

The US FDA is now investigating post marketing reports of serious bleeding events in patients tak
The US FDA is now investigating post marketing reports of serious bleeding events in patients taking dabigatran. FDA is working to More »

Telaprevir effective in hard-to-treat cirrhotic HCV
Adding the recently approved protease inhibitor telaprevir to pegylated interferon (peginterferon) plus ribavirin therapy achieved a 47% sustained viral response (SVR) in hard-to-treat patients with hepatitis C virus (HCV) infection and cirrhosis who had previously failed the standard More »